Processes

What will AGI do for Validate targets?

A preliminary biological target, such as a gene or protein associated with a disease, is nominated from early discovery efforts.

Trigger: A preliminary biological target, such as a gene or protein associated with a disease, is nominated from early discovery efforts.
Outcome: The biological target is definitively confirmed as viable for therapeutic intervention or rejected due to lack of efficacy or safety.

The work itself

Grounded Work Profile

Receive nominated biological targets from the discovery phaseprocessProfile
Conduct genetic and biochemical assays to test disease correlationprocessProfile
Perform in vitro and in vivo experiments to confirm target engagementprocessProfile
Assess preliminary safety and toxicity risks of target modulationprocessProfile
Analyze validation data to determine therapeutic potentialprocessProfile
Approve or reject the target for lead compound screeningprocessProfile

How AGI delivers it

Services-as-Software
Get the professional outcome delivered as software, priced on results, not headcount.
Services.do
Autonomous Agents as digital employees
Hire a digital employee that does the job under earned, supervised autonomy.
Agents.do
Business-as-Code
Encode how your work runs, once, as software that executes itself.
Platform.do

Value flow

Go deeper